Masimo Corp (MASI) released its first quarter results on Tuesday, April 27, 2021. The company reported net earnings of $0.92 per share for the first quarter ending March 31, 2021. Earnings for this past quarter declined 18 percent compared to the same period a year ago.
The company provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, physician offices, long term care facilities, veterinarians, and consumers; and non-medical/consumer products through e-commerce site, masimopersonalhealth.com. Masimo Corporation develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry.
Masimo's revenue increased 20 percent over the past trailing twelve-month period versus the previous twelve-month period. Gross margins decreased to 69.61% for the first quarter compared to the same period in the previous year, and operating margins decreased to 22.89% over the same period. Net earnings for past trailing twelve months were $229.23 million, up 8% from the prior year.
Moving on to the balance sheet, Masimo’s cash levels dropped 9% for the third quarter over the same period last year. Overall liquidity of the balance sheet, as measured by the current ratio, decreased 19.86% this past year. The current ratio for Masimo now stands at 4.99. The company increased shares outstanding by 2.9%.
Shares of MASI are currently trading around $229.32. In terms of valuation, the stock is trading at a trailing twelve-month price to earnings ratio of 58.21 and price to book ratio of 10.0.
_____
This article was written by Value Investing News (https://www.valueinvestingnews.com) on Wednesday, April 28, 2021.